To investigate the causes of recurrent trigeminal neuralgia (RTN) and to evaluate the efficacy of microvascular decompression (MVD) plus longitudinal nerve sectioning (LNS) or LNS only for RTN patients who have undergone multiple procedures.
Original Investigation
█ INTRODUCTION I diopathic trigeminal neuralgia (TN) is a facial pain syndrome. The incidence of idiopathic TN is reported as 1 to 2/10000 (21) . It is usually qualified by sharp, paroxysmal, unilateral and electric shock-like pain in branches of the trigeminal nerve, accompanied with innocuous triggers (25) . However, the exact pathophysiology of TN is not well studied yet. As reported, the leading etiology hypothesis focuses on vascular compression at the root entry zone (REZ) of the trigeminal nerve (17, 23, 28) . The effectiveness of microvascular decompression (MVD) for idiopathic TN supports this argument (3, 24, 35) .
Studies have shown that the success rate of MVD tends to reduce over time. Approximately 22-42% of patients suffer from recurrent TN 5 years after MVD treatment, and careful decisions with respect to additional treatment must be made (5, 24) . Whether to use surgical or non-surgical methods to treat patients with recurrent TN has long been a controversial issue, and potential treatments include MVD, percutaneous glycerol rhizotomy, percutaneous radiofrequency rhizotomy, stereotactic radiosurgery, and percutaneous balloon compression. The purpose of this study was to discuss the outcomes of MVD plus LNS or LNS only for patients with recurrent TN.
We also explored the possible causes of the disorder based on the observations during surgery.
█ MATERIAL and METHODS
This study was approved by the institutional review board of Shanghai Ninth People's Hospital.
Inclusion and Exclusion Criteria
A total of 376 patients with idiopathic TN accepted to undergo surgery at the department of Neurosurgery of our hospital from June 2008 to December 2014. Among them, 21 patients suffered from recurrent TN, even after several destructive surgical treatments, and ultimately accepted a treatment protocol of MVD plus LNS or LNS alone. The primary indications were typical, drug-resistant TN (the International Headache Society criteria), or drug-responsive TN but with severe drugrelated adverse effects, without absolute contraindications to general anesthesia (12) . The exclusion criteria were as follows: 1) patients who had failed initial surgeries; 2) patients who had a pain-free period after the initial surgical treatment; 3) patients with absolute contraindications to general anesthesia; 4) patients who did not choose MVD plus LNS treatment for recurrent TN; 5) patients whose data were not complete; and 6) patients who had any other surgery in the posterior fossa, such as tumor removal, vascular malformations and congenital malformations.
Data Collection
The medical records of all patients were reviewed. The data collected, included age, sex, treatment before surgery, pain severity and distribution, findings during surgery, immediate postoperative BNI, final follow-up BNI, associated comorbidities (e.g., cardiovascular diseases, arterial hypertension, and diabetes), and complications. The severity of pre-and postoperative pain was scored using the Barrow Neurological institute (BNI) Pain Intensity Scale Score. Statistics were analyzed with the mean, minimum and maximum range for continuous data. The enumeration data were expressed as percentages.
Surgical Procedures
MVD plus LNS was performed through a suboccipital restrosigmoid approach. Briefly, the patients were placed in the supine position, with the affected side up, the ear parallel to the floor, and the chin flexed (22) . A standard 5 cm to 7 cm linear retroauricular incision was made. Then, if necessary, the existing cranioplasty material was completely removed. We removed the additional bone to visualize the edges of the sigmoid sinus and the transverse sinus. The craniotomy required was less than 3×2 cm. The dura was incised to form a flap, and the upper external posterior cranial fossa was fully exposed until the trigeminal nerve roots were clearly observed. The arachnoid membrane surrounding the trigeminal nerves was opened to expose REZ.
During the surgery, new Teflon felt pieces were used to separate the third nerve from the offending vessels. Then, the nerve fibers were divided longitudinally into several respective bundles, from the REZ to the petrous bone, by using a straight blunt-tip bayonet probe. If necessary, the fibers were combed without evidence of compression. After surgery, the surgical incision was closed very carefully. During the surgery, the medical microscope video recorder system was used to record the intracranial details. All patients included in this study were operated on by one neurosurgeon, Zhi-Lin Guo.
Follow-up and the Post-Operative Outcome Assessments
All patients were telephoned and outpatient follow-ups were performed. The follow-up period ended on October 30, 2016. The Barrow Neurological Institute (BNI) scoring system was used to evaluate the degree of pain relief. According to Figure  4 , the TN was divided into five grades, depending on the severity of pain and the response to medicine (27) . Independent observers, who were not involved in patient management or surgeries, managed follow-ups through outpatient services or telephone and also recorded complications and recurrences. General inquiry, facial nerve tests and hearing tests were performed during the follow-ups.
█ RESULTS
A total of 376 patients were analyzed in this study, of whom 150 were men and 226 were women. The mean age at MVD was 58.2 ± 10.3 years old (range: 26.4-78.7 years). The length of follow-up was from 21 to 98 months (mean: 59.2 ± 26.3 months). There were 18 patients with diabetes mellitus, 27 with cardiovascular disease and 96 with arterial hypertension. The demographic characteristics of the patients in our study are shown in Table I . Among them, 21 patients suffered from recurrent TN after multiple destructive surgical treatments, performed at other medical institutions, including microvascular decompression (MVD), percutaneous glycerol rhizotomy (PGR) , stereotactic radiosurgery (SRS), botulinum neurotoxin (BoNT) and percutaneous balloon compression (PBC) ( Table II) . Ultimately 12 patients accepted MVD plus (Table II) . The mean age of the patients at the time of surgery was 59.6 ± 11.0 years old (range 39-78 years old). The follow-up period after the latest surgery ranged from 22 to 68 months (mean 38.3 ± 15.2 months). During the followup period, relief from symptoms was observed in all cases. The demographic characteristics of the patients are shown in Table II .
Preoperative Imaging and Operative Findings
The pre-operative MRTA of 18 patients (18/21, 85.7%) showed positive results, consistent with the observations during operations. During the surgery the following were discovered: arterial compression in 7 patients (33.3%); venous compression in 2 patients (4.8%); arterial combined with venous compression in 2 patients (9.5%); Teflon granulomas in 1 patient (4.8%); and nothing except arachnoid adhesion in 9 cases (42.9%) (Table III) . Arachnoid adhesion was found in 20 out of the 21 patients (95.2%) and was dissected during surgery.
Teflon granulomas have been considered to be responsible for recurrent TN. During the operations, a Teflon granuloma was found in the cerebellopontine angle and was in touch with the trigeminal nerve in 1 of the 21 patients. As shown in Figure 1 , the mass was a low-intensity signal in the T2-weighted MRI 
Complications of MVD plus LNS or LNS Only Operations
Complications of the operation included cerebrospinal fluid leakage in 1 patient (4.76%) and bacterial meningitis in 1 patient (4.76%); however, the bacterial meningitis and cerebrospinal fluid leakage were resolved after appropriate treatment. Facial numbness occurred in 21 patients (100%) immediately after surgery and 18 patients (85.7%) still experienced facial numbness at the end of the follow-up period. No patients died, and no sensory deficits or other cranial nerve deficits such as hearing loss were noted (Table IV) .
█ DISCUSSION MVD is accepted as one of the effective treatments for idiopathic TN (10) . Although the long-term pain relief rate of MVD is 71%-84%, not all patients experience recovery after the procedure (5, 10, 14, 24, 29, 30, 34) . In fact, some patients experience recurrent TN pain at a recurrence rate of 1-5% every year (3, 4, 6, 32) .
The options for the effective treatment of recurrent TN patients are controversial. Only a few studies have examined the outcome of MVD plus LNS or LNS only. Percutaneous balloon compression, gamma knife surgery, and repeated MVD have previously been reported to treat patients with recurrent TN, but the results were not very satisfactory (2, 11, 16, 31) . In our study, almost all patients (19/21, 90.5%) reported pain relief 36.1 months after the procedure, 15 patients (71.4%) reported being pain free (BNI score I), and 4 patients (19.0%) reported pain relief (BNI II-III).
Two possible explanations for the effectiveness of this surgical method were analyzed. One explanation is that the vascular contact was dissected at the REZ of the third cranial nerve (28, 31) . The other explanation is that the continuity of the axon was destroyed by combing the nerve, not only resulting in a under MRTA. During the surgical procedures, the mass was removed and the nerve fibers were combed gently, as seen in Figure 3 .
Follow-up and Outcome Assessments
The MVD plus LNS or LNS only treatments offered a high degree of pain relief for patients suffering from recurrent TN pain. All 21 patients reported immediate pain relief after the surgeries. Among them, 19 cases (90.5%) had a BNI score of I, and 2 cases (9.5%) had a BNI score of II (Table III) . At the end of the follow-up period, 15 patients (71.4%) had BNI I, 3 cases (14.3%) had BNI II and 1 case (4.8%) experienced BNI III. The final 2 patients (9.5%) had BNI scores of IV and controlled their pain with medication. was found between the third cranial nerve and the new venous compression of the trigeminal nerve. We hypothesize that the new compression is responsible for the return of TN. Vascular compression is mainly caused by progressive blood vessel changes, which is associated with the normal aging process, such as arteriosclerosis. Arachnoid adhesions and thickening, which decrease the cerebellopontine angle area, increase the probability of blood vessels contacting the trigeminal nerve.
A Teflon granuloma, as shown in Figure 2 , was found in 1 patient (4.8%), ventral to the trigeminal nerve. As is known, Teflon granulomas occur in 1.1-7.3% of all MVD cases performed in accordance with Jannetta's procedure (7, 8, 26) . They cause pain in 13-50% of recurrent neuralgia patients (1, 8, 9) . The most common giant cell inflammatory responses associated with Teflon applications have been described in orthopedics, maxillofacial surgery, and otolaryngology (13, 15, 33) .
Surgery can induce arachnoid thickening or unusual adhesions, which complicates the anatomical relationship between the cranial nerve and adjacent vascular structures. In our study, arachnoid adhesion was found in almost all patients (20/21, 95.2%). Arachnoid adhesion and thickening reduce the cerebellopontine angle area, increasing the probability of blood vessels contacting the trigeminal nerve. This could help to make a connection between the trigeminal nerve and offending vessels. The pulse through the offending vessels was transmitted to the nerve more easily, and the flow of cerebrospinal fluid or changes in patient position made the pad shift. However, we doubted that the thickening arachnoid bound the trigeminal nerve.
The primary complication of MVD plus LNS or LNS only treatment was facial numbness in this study. The patients had previously received MVD treatment, and after the recurrence of post-operative pain they were also treated with MVD, BoNT, SRS, PBC or PGR. However, pain continued to recur, and they sought pain relief at our institution. With the addition of longitudinal nerve sectioning, we could accurately observe the position of the corresponding nerve bundle during the surgery and then comb the trigeminal nerve. This technique can effectively relieve pain, but it is also one of the causes of post-operative facial numbness. Other operational techniques can also result in pain relief, but these surgical procedures can also cause facial numbness, to some extent. Ko et al. reported that patients treated with internal neurolysis experienced numbness, but the numbness did not obviously affect their quality of life (20) . Gao et al. also reported that MVD and LNS resulted in almost complete pain relief and reduction of the electrical excitability that was being produced by abnormal afferent trigeminal fibers, but causing partial injury to sensory nerves (18) (19) (20) 36) . During our procedure, we found that the operative route was full of arachnoid thickening and adhesions. The arachnoid membrane bound the trigeminal nerve and could not be released by the sharpness of separation alone; we therefore added longitudinal nerve sectioning. Pain disappeared in nine patients after treatment by LNS only, and the effect was significant. Therefore, we thought the technique of MVD plus LNS could be more effective for patients who had previously received several traumatic surgeries. However, trauma to the trigeminal root does not appear to be the mechanism for facial numbness. Facial numbness could be caused by other lesioning techniques, such as BoNT, SRS, PBC or PGR. However, the MVD plus LNS or LNS only techniques can used by any surgical center where MVD can be performed, even in remote hospitals. Above all, this procedure can be performed in patients without vascular compression.
The causes of recurrent TN were commonly considered to be vascular compression and arachnoid adhesion, followed by Teflon granulomas.
In this study vascular compression involving the following components was observed: vessel loops were observed in 11 cases (50.0%), the superior cerebellar artery was observed in 2 cases (9.5%), the anterior inferior cerebellar artery was observed in 5 cases (23.8%), the petrosal vein was observed in 2 cases (9.5%), and the anterior inferior cerebellar artery combined with the petrosal vein was observed 2 cases (9.5%). According to the records of previous operations for multiple patients, venous compression of the third cranial nerve was located and removed, and patients reported pain relief after the operations. During the procedures in our hospital, Teflon with few complications (13) . In our study, although 6 patients experienced facial numbness prior to the procedure, new facial numbness existed in all patients immediately after the operation and 18 patients (85.7%) still suffered from facial numbness at the end of the follow-up period. This result is believed to be associated with the removal of the Teflon or the combing of the nerve fibers (Table IV) .
This study has several limitations. First, all patients were studied retrospectively. This study did not compare the effectiveness, the recurrence rate or the complication rate of different surgical methods, all of which require further study. Second, the sample size was small, and was not enough to conduct a precise analysis. Third, the follow-up period was relatively short. Therefore, larger studies are needed to be conducted over longer periods than 10 years to find a more effective treatment for recurrent TN after multiple procedures.
█ CONCLUSION
The study certifies that vascular compression, arachnoid adhesion and Teflon granulomas were the causes of recurrent trigeminal neuralgia. MVD plus LNS and LNS only are both feasible therapeutic options with good probabilities of success, especially after multiple neurodestructive procedures.
